trish.wilson

For Aubrey de Grey, the best known longevity thought leader and chief science officer of the Silicon Valley-based SENS Research Foundation, Covid-19 has made the case clear: we must make elderly people in our populations more resilient.

“It is completely unarguable that ageing is bad for you,” says Mr de Grey, a self-proclaimed provocateur and committed scientist. Almost mystical in appearance, he stands at the crossroads of the mainstream and peripheral – where the longevity sub-sector itself can also be found. 

Read what Sergey has to say about Jim here: https://www.linkedin.com/posts/sergeyyoung_sergeyyoung-longevity-investment-activity-6759161578949509120-Zg8M

Click to listen to podcast

In this episode of Bulletproof Radio, Juvenescence co-author Jim Mellon discusses the revolutionary changes that we’ve experienced in the last 20 years in the world of ageing. From scientific breakthroughs on the human genome to staying healthier with cellular agriculture, the conversation on ageing is changing so we can live healthier lives for longer.

Obesity plays a role in as many as 12 types of cancer, according to a major analysis of the causes of the disease.

The report by the World Cancer Research Fund (WCRF) found that while smoking remains the biggest cause of cancer, it may soon be overtaken by obesity in many countries, including the UK. In an earlier version of the report, released a decade ago, the WCRF identified seven cancers linked to obesity. Now, it says, the evidence points to 12: liver, ovaries,
prostate (advanced), stomach, mouth and throat, bowel, breast (post menopause), gall bladder, kidney, oesophagus, pancreas and womb. The report says that up to four in ten cancer cases are preventable, and urges non-smokers to adopt a ten-point health plan, which includes cutting down on bacon and processed meats, being physically active and reducing alcohol intake.

Read more at The Guardian

This is how much 20mg of paroxetine (Paxil in the US or Seroxat in the UK), an antidepressant that is now out of patent, costs around the world.

Source: Drugwatch.com